As symptoms in OPMD predominantly affect skeletal muscles, others and we suggested that in muscles of OPMD patients PABPN1 levels decline below a critical threshold leading to molecular aberrations and cellular defects [12, 13]. The gene discussed is PABPN1; the disease is oculopharyngeal muscular dystrophy.